Heard On The Street: Dealers Spot Action In ZEEL, GAIL, Piramal Pharma, IndiGo, Mazagon Dock And More

NDTV Profit India has been tracking the action in the top dealing rooms of India’s financial capital, and this edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Zee Entertainment, GAIL, Piramal Pharma, InterGlobe Aviation, Indian Hotels, Mazagon Dock and Biocon.

Heard On The Street provides readers with what well-informed investors, especially HNIs, FIIs, DIIs, and mutual funds, are buying and selling in the stock market. It also tracks the latest unconfirmed/unverified chatter around stocks and/or sectors.

NDTV Profit picked up the following cues from the dealing room chatter during trade:

Zee Entertainment

The company has a board meeting today to discuss the investment banker's recommendations, and as per dealers, there could be announcements regarding stake sales in OTT and some internal clean-up.

GAIL

Dealers indicate that domestic institutional investors continue to accumulate the counter at lower levels on the back of positive announcements related to pipeline tariff hikes, new gas transmission policy and monetisation of pipeline infrastructure.

Piramal Pharma

Dealers indicate that there could be a potential block deal soon from Carlyle, which owns close to an 8% stake.

IndiGo and Indian Hotels

There is a buzz of a potential block deal in both the counters this week.

Mazagon Dock

Dealers indicate that large, high-net-worth individuals have accumulated the counter on today’s fall.

Biocon

The company could soon launch a fundraise via QIP as per dealers. The price could be at a discount of 5-8% compared to the current market prices. Dealers indicate strong demand.

Disclaimer: The mentioned stocks capture NDTV Profit's dealing room channel checks during trading hours. The information provided is for informational purposes. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information. This content does not constitute financial, investment, or trading advice and should not be construed as a recommendation to buy, sell, or hold any securities.